DAXOR CORP

Regulatory Filings • Dec 15, 2021

40-17F2 1 form40-17f2.htm

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-17f-2

Certificate of Accounting of Securities and Similar

Investments in the Custody of

Management Investment Companies

Pursuant to Rule 17f-2 [17 CFR 270.17f-2]

| 1.
Investment Company Act File Number: 811-22684 | | | | Date
examination completed: | |
| --- | --- | --- | --- | --- | --- |
| | | | | September
30, 2021 | |
| 2.
State identification Number: | | | | | |
| AL | AK | AZ | AR | CA | CO |
| CT | DE | DC | FL | GA | HI |
| ID | IL | IN | IA | KS | KY |
| LA | ME | MD | MA | MI | MN |
| MS | MO | MT | NE | NV | NH |
| NJ | NM | NY X | NC | ND | OH |
| OK | OR | PA | RI | SC | SD |
| TN | TX | UT | VT | VA | WA |
| WV | WI | WY | PUERTO
RICO | | |
| Other (specify): | | | | | |
| 3.
Exact name of investment company as specified in registration statement: | | | | | |
| Daxor
Corporation | | | | | |
| 4.
Address of principal executive office (number, street, city, state, zip code): | | | | | |
| 109
Meco Lane, Oak Ridge, TN 37830 | | | | | |

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

MANAGEMENT STATEMENT REGARDING COMPLIANCE WITH CERTAIN PROVISIONS OF THE INVESTMENT COMPANY ACT OF 1940

December 15, 2021

We, as members of management of Daxor Corporation (the “Company”), are responsible for complying with the requirements of subsections (b) and (c) of Rule 17f-2, “Custody of Investments by Registered Management Investment Companies,” of the Investment Company Act of 1940. We are also responsible for establishing and maintaining effective internal controls over compliance with those requirements. We have performed an evaluation of the Company’s compliance with the requirements of subsections (b) and (c) of Rule 17f-2 as of September 30, 2021, and from July 1, 2021 through September 30, 2021.

Based on this evaluation, we assert that the Company was in compliance with the requirements of subsections (b) and (c) of Rule 17f-2 of the Investment Company Act of 1940 as of September 30, 2021, and from July 1, 2021 through September 30, 2021, with respect to securities reflected in the investment accounts of the Company.

Daxor Corporation

| /s/
Michael Feldschuh |
| --- |
| Michael Feldschuh |
| President and Chief Executive Officer |
| /s/ Robert
J. Michel |
| Robert J. Michel |
| Chief Financial Officer and Chief Compliance Officer |

Field: Page; Sequence: 2

Field: /Page

Report of Independent Accountants

To the Management and Board of Directors of Daxor Corporation

We have examined management’s assertion, included in the accompanying Management Statement Regarding Compliance with Certain Provisions of the Investment Company Act of 1940, that Daxor Corporation, (the Company) complied with the requirements of subsections (b) and (c) of Rule 17f-2 of the Investment Company Act of 1940 as of September 30, 2021. Management is responsible for the Company’s assertion about compliance with subsections (b) and (c) of Rule 17f-2 of the Act (the “specified requirements”). Our responsibility is to express an opinion on management’s assertion about the Company’s compliance based on our examination.

Our examination was conducted in accordance with attestation standards established by the American Institute of Certified Public Accountants. Those standards require that we plan and perform the examination to obtain reasonable assurance about whether management’s assertion about compliance with the specified requirements is fairly stated, in all material respects. An examination involves performing procedures to obtain evidence about whether management’s assertion is fairly stated, in all material respects. The nature, timing and extent of the procedures selected depend on our judgment, including an assessment of the risks of material misstatement of management’s assertion, whether due to fraud or error. We believe that the evidence we obtained is sufficient and appropriate to provide a reasonable basis for our opinion.

Included among our procedures were the following tests performed as of September 30, 2021, and with respect to the agreement of security purchases and sales, for the period from July 1, 2021 through September 30, 2021:

| ● | Confirmation
of all securities held by institutions in book entry form with the qualified custodian without prior notice to management; |
| --- | --- |
| ● | Reconciliation
of all such securities to the books and records of the Company and the qualified custodian; |
| ● | Agreement
of all security transactions for the period from July 1, 2021 through September 30, 2021 from the books and records of the Company
to the qualified custodian confirmations. |

Our examination does not provide a legal determination on the Company’s compliance with specified requirements.

In our opinion, management’s assertion that Daxor Corporation complied with the requirements of subsections (b) and (c) of Rule 17f-2 of the Investment Company Act of 1940 as of September 30, 2021, with respect to securities reflected in the investment account of the Company is fairly stated, in all material respects.

This report is intended solely for the information and use of management and the Board of Directors of Daxor Corporation and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

Iselin, New Jersey

December 14, 2021

Baker Tilly US, LLP, trading as Baker Tilly, is a member of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities. © 2020 Baker Tilly US, LLP

Field: Page; Sequence: 3; Options: Last

Field: /Page